SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
EVOLUTION OF ANTIBODY RESPONSES TO SARS-CoV-2 INFECTION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
NEUTRALIZING-ANTIBODY RESPONSES FOLLOWING SARS-COV-2 INFECTION (ABSTRACT
256)
Juan M Tiraboschi
Hospital Universitari de Bellvitge, Barcelona, Spain
SARS-COV-2 NEUTRALIZING-ANTIBODY RESPONSES IN CONVALESCENT INDIVIDUALS IN US AND PERU (ABSTRACT
257)
Shelly Karuna
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
PERFORMANCE AND DYNAMIC CHANGE IN SARS-COV-2 ANTIBODY RESPONSES (ABSTRACT
258)
Grace Kenny
University College Dublin, Donnybrook East, Dublin, Ireland
STABLE NEUTRALIZING-ANTIBODY LEVELS 6 MONTHS AFTER MILD AND SEVERE COVID-19 EPISODE (ABSTRACT
259)
Edwards Pradenas
IrsiCaixa AIDS Research Institute, Badalona, Spain
PERSISTENCE OF SARS-COV-2 –SPECIFIC AB RESPONSE IN HIV+ INDIVIDUALS ON ART (ABSTRACT
260)
Maria L Alcaide
University of Miami Miller School of Medicine, Miami, FL, USA
BINDING SIGNATURES AND CROSS-REACTIVITY IN THE SARS-COV-2 IMMUNE RESPONSE (ABSTRACT
261)
Caitlin Stoddard
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
CHARACTERIZATION OF SARS-COV-2–SPECIFIC RESPONSES IN PEOPLE LIVING WITH HIV (ABSTRACT
262)
Aljawharah Saleh Z Alrubayyi
University of Oxford, Headington Oxford, United Kingdom
ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION BY CONVALESCENT PLASMA (ABSTRACT
263)
Alex Sigal
African Health Research Institute (AHRI), Durban, KZN, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
